These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35915495)

  • 1. Effectiveness of the 10-valent pneumococcal conjugate vaccine on pediatric pneumonia confirmed by ultrasound: a matched case-control study.
    Checkley W; Hossen S; McCollum ED; Pervaiz F; Miele CH; Chavez MA; Moulton LH; Simmons N; Roy AD; Chowdhury NH; Ahmed S; Begum N; Quaiyum A; Santosham M; Baqui AH
    Respir Res; 2022 Aug; 23(1):198. PubMed ID: 35915495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the 10-valent pneumococcal conjugate vaccine against radiographic pneumonia among children in rural Bangladesh: A case-control study.
    McCollum ED; Ahmed S; Roy AD; Chowdhury NH; Schuh HB; Rizvi SJR; Hanif AAM; Khan AM; Mahmud A; Pervaiz F; Harrison M; Reller ME; Simmons N; Quaiyum A; Begum N; Santosham M; Checkley W; Moulton LH; Baqui AH;
    Vaccine; 2020 Sep; 38(42):6508-6516. PubMed ID: 32873404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studies.
    Baqui AH; Koffi AK; McCollum ED; Roy AD; Chowdhury NH; Rafiqullah I; Ahmed ZB; Mahmud A; Begum N; Ahmed S; Khanam R; Harrison M; Simmons N; Hossen S; Islam M; Quaiyum A; Checkley W; Santosham M; Moulton LH; Saha SK;
    Vaccine; 2021 Sep; 39(40):5794-5801. PubMed ID: 34465471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data.
    Diaz J; Terrazas S; Bierrenbach AL; Toscano CM; Alencar GP; Alvarez A; Valenzuela MT; Andrus J; del Aguila R; Hormazábal JC; Araya P; Pidal P; Matus CR; de Oliveira LH
    PLoS One; 2016; 11(4):e0153141. PubMed ID: 27058873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study.
    Domingues CM; Verani JR; Montenegro Renoiner EI; de Cunto Brandileone MC; Flannery B; de Oliveira LH; Santos JB; de Moraes JC;
    Lancet Respir Med; 2014 Jun; 2(6):464-71. PubMed ID: 24726406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal Conjugate Vaccine impact assessment in Bangladesh.
    Baqui AH; McCollum ED; Saha SK; Roy AK; Chowdhury NH; Harrison M; Hanif AAM; Simmons N; Mahmud A; Begum N; Ahmed S; Khan AM; Ahmed ZB; Islam M; Mitra D; Quaiyum A; Chavez MA; Pervaiz F; Miele CH; Schuh HB; Khanam R; Checkley W; Moulton LH; Santosham M
    Gates Open Res; 2018 Apr; 2():21. PubMed ID: 29984359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of 10-valent pneumococcal conjugate vaccine estimated with three parallel study designs among vaccine-eligible children in Finland.
    Rinta-Kokko H; Auranen K; Toropainen M; Nuorti JP; Nohynek H; Siira L; Palmu AA
    Vaccine; 2020 Feb; 38(6):1559-1564. PubMed ID: 31791813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial.
    Lucero MG; Nohynek H; Williams G; Tallo V; Simões EA; Lupisan S; Sanvictores D; Forsyth S; Puumalainen T; Ugpo J; Lechago M; de Campo M; Abucejo-Ladesma E; Sombrero L; Nissinen A; Soininen A; Ruutu P; Riley I; Mäkelä HP
    Pediatr Infect Dis J; 2009 Jun; 28(6):455-62. PubMed ID: 19483514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study.
    Lawrence H; Pick H; Baskaran V; Daniel P; Rodrigo C; Ashton D; Edwards-Pritchard RC; Sheppard C; Eletu SD; Litt D; Fry NK; Rose S; Trotter C; McKeever TM; Lim WS
    PLoS Med; 2020 Oct; 17(10):e1003326. PubMed ID: 33095759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of the 13-valent pneumococcal conjugate vaccine against adult pneumonia in Italy: a case-control study in a 2-year prospective cohort.
    Prato R; Fortunato F; Cappelli MG; Chironna M; Martinelli D
    BMJ Open; 2018 Mar; 8(3):e019034. PubMed ID: 29581200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age.
    Lucero MG; Dulalia VE; Parreno RN; Lim-Quianzon DM; Nohynek H; Makela H; Williams G
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004977. PubMed ID: 15495133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of 10-valent pneumococcal conjugate vaccine against vaccine-type invasive pneumococcal disease in Pakistan.
    Riaz A; Mohiuddin S; Husain S; Yousafzai MT; Sajid M; Kabir F; Rehman NU; Mirza W; Salam B; Nadeem N; Pardhan K; Khan KMA; Raza SJ; Arif F; Iqbal K; Zuberi HK; Whitney CG; Omer SB; Zaidi AKM; Ali A;
    Int J Infect Dis; 2019 Mar; 80():28-33. PubMed ID: 30576865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Pneumococcal Conjugate Vaccines of Different Valences Against Invasive Pneumococcal Disease Among Children in Taiwan: A Nationwide Study.
    Su WJ; Lo HY; Chang CH; Chang LY; Chiu CH; Lee PI; Lu CY; Hsieh YC; Lai MS; Lin TY
    Pediatr Infect Dis J; 2016 Apr; 35(4):e124-33. PubMed ID: 26974752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study.
    Cohen C; von Mollendorf C; de Gouveia L; Naidoo N; Meiring S; Quan V; Nokeri V; Fortuin-de Smit M; Malope-Kgokong B; Moore D; Reubenson G; Moshe M; Madhi SA; Eley B; Hallbauer U; Kularatne R; Conklin L; O'Brien KL; Zell ER; Klugman K; Whitney CG; von Gottberg A;
    Clin Infect Dis; 2014 Sep; 59(6):808-18. PubMed ID: 24917657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact and effectiveness of the 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children under 5 years of age in the Netherlands.
    Peckeu L; van der Ende A; de Melker HE; Sanders EAM; Knol MJ
    Vaccine; 2021 Jan; 39(2):431-437. PubMed ID: 33243632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early impact of 10-valent pneumococcal conjugate vaccine in childhood pneumonia hospitalizations using primary data from an active population-based surveillance.
    Sgambatti S; Minamisava R; Bierrenbach AL; Toscano CM; Vieira MA; Policena G; Andrade AL
    Vaccine; 2016 Jan; 34(5):663-670. PubMed ID: 26706272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands.
    Gessner BD; Jiang Q; Van Werkhoven CH; Sings HL; Webber C; Scott D; Gruber WC; Grobbee DE; Bonten MJM; Jodar L
    Vaccine; 2019 Jul; 37(30):4147-4154. PubMed ID: 31155413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of pneumococcal conjugate vaccine against presumed bacterial pneumonia hospitalisation in HIV-uninfected South African children: a case-control study.
    Madhi SA; Groome MJ; Zar HJ; Kapongo CN; Mulligan C; Nzenze S; Moore DP; Zell ER; Whitney CG; Verani JR
    Thorax; 2015 Dec; 70(12):1149-55. PubMed ID: 26092924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.
    Domínguez Á; Ciruela P; Hernández S; García-García JJ; Soldevila N; Izquierdo C; Moraga-Llop F; Díaz A; F de Sevilla M; González-Peris S; Campins M; Uriona S; Martínez-Osorio J; Solé-Ribalta A; Codina G; Esteva C; Planes AM; Muñoz-Almagro C; Salleras L
    PLoS One; 2017; 12(8):e0183191. PubMed ID: 28806737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland.
    Rinta-Kokko H; Palmu AA; Auranen K; Nuorti JP; Toropainen M; Siira L; Virtanen MJ; Nohynek H; Jokinen J
    Vaccine; 2018 Apr; 36(15):1934-1940. PubMed ID: 29526371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.